Clinical course after radiofrequency ablation of type I atrial flutter. Identification of patients who risk atrial arrhythmia recurrences

European Heart Journal

Volumn 23, Issue 6, 2002, Pages 441-443

  Brembilla Perrot, B ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; CATHETER ABLATION; EDITORIAL; FOLLOW UP; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HIGH RISK PATIENT; HUMAN; MITRAL VALVE REGURGITATION; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SAFETY; STROKE; THROMBOEMBOLISM; TREATMENT PLANNING;

ATRIAL FLUTTER; CATHETER ABLATION; HUMANS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 0036522098     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.2912     Document Type: Editorial

References (12)

1. Shively BK, Gelgand EA, Crawford MH. Regional left atrial stasis during atrial fibrillation and flutter determinants and relation to stroke. J Am Coll Cardiol 1996; 27: 1723-9.
2. Biblo LA, Yuan Z, Quan KJ, Mackall JA, Rimm AA. Risk of stroke in patients with atrial flutter. Am J Cardiol 2001; 87: 346-9.
3. Roithinger FX, Karch MR, Steiner PR, Sippensgroenewegen A, Lesh M. Relationships between atrial fibrillation and typical atrial flutter in humans. Activation sequence changes during spontaneous cardioversion. Circulation 1997; 96: 3484-91.
4. Nabar A, Rodriguez LM, Timmermans C, Smeets JLRM, Wellens HJJ. Radiofrequency ablation of 'class IC atrial flutter' in patients with resistant atrial fibrillation. Am J Cardiol 1999; 83: 785-7.
5. Schumacher B, Jung W, Lewalter T, Valhaus C, Wolpert C, Lüderitz B. Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation. Am J Cardiol 1999; 83: 710-3.
6. Stabile G, De Simone A, Turco P et al. Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation. J Am Coll Cardiol 2001; 37: 1639-44.
7. Crijns HJGM, Van Gelder IC, Tieleman RG et al. Long-term outcome of electrical cardioversion in patients with chronic atrial flutter. Heart 1997; 77: 56-61.
8. Natale A, Newby KH, Pisano E et al. Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol 2000; 35: 1898-904.
9. Paydak H, Kall JG, Burke MC, Rubenstein D, Koop RJ, Wilber DJ. Atrial fibrillation after radiofrequency ablation of type I atrial flutter. Time to onset, determinants, and clinical course. Circulation 1998; 98: 315-22.
10. Anselme F, Saoudi N, Poty H, Douillet R, Cribier A. Radiofrequency catheter ablation of common atrial flutter. Significance of palpitations and quality-of-life evaluation in patients with proven isthmus block. Circulation 1999; 99: 534-40.
11. Da Costa A, Romeyer C, Mourot S et al. Factors associated with early atrial fibrillation after ablation of common atrial flutter. A single centre prospective study. Eur Heart J 2002; 23: 498-506, doi:10.1053/euhj.2001.2819
12. Luchsinger JA, Steinberg JS. Resolution of cardiomyopathy after ablation of atrial flutter. J Am Coll Cardiol 1998; 32: 205-10.